These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 24316903)

  • 1. Lipid profile and anti-TNF-α use.
    Ferraz Filho AC; dos Santos LP; Silva MB; Skare TL
    Rev Bras Reumatol; 2013; 53(5):444-7. PubMed ID: 24316903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis.
    Seriolo B; Paolino S; Sulli A; Fasciolo D; Cutolo M
    Ann N Y Acad Sci; 2006 Jun; 1069():414-9. PubMed ID: 16855168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.
    Popa C; van den Hoogen FH; Radstake TR; Netea MG; Eijsbouts AE; den Heijer M; van der Meer JW; van Riel PL; Stalenhoef AF; Barrera P
    Ann Rheum Dis; 2007 Nov; 66(11):1503-7. PubMed ID: 17472994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-α inhibitor use is not associated with lipid changes in rheumatoid arthritis.
    Bili A; Morris SJ; Sartorius JA; Kirchner HL; Antohe JL; Dancea S; Wasko MC
    J Rheumatol; 2012 May; 39(5):946-8. PubMed ID: 22467937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid profile changes in patients with rheumatic diseases receiving a treatment with TNF-α blockers: a meta-analysis of prospective studies.
    Di Minno MN; Ambrosino P; Peluso R; Di Minno A; Lupoli R; Dentali F;
    Ann Med; 2014 Mar; 46(2):73-83. PubMed ID: 24460516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis.
    van Sijl AM; Peters MJ; Knol DL; de Vet RH; Sattar N; Dijkmans BA; Smulders YM; Nurmohamed MT
    Semin Arthritis Rheum; 2011 Dec; 41(3):393-400. PubMed ID: 21665247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of TNF-α inhibitor on lipid profile and atherogenic index of plasma in axial spondyloarthritis: 2-year follow-up data from the Catholic Axial Spondyloarthritis COhort (CASCO).
    Min HK; Lee J; Ju JH; Park SH; Kwok SK
    Clin Rheumatol; 2020 Feb; 39(2):471-477. PubMed ID: 31486930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis.
    Cauza E; Cauza K; Hanusch-Enserer U; Etemad M; Dunky A; Kostner K
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):1004-7. PubMed ID: 12635469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis.
    Kiortsis DN; Mavridis AK; Filippatos TD; Vasakos S; Nikas SN; Drosos AA
    J Rheumatol; 2006 May; 33(5):921-3. PubMed ID: 16541480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.
    Spanakis E; Sidiropoulos P; Papadakis J; Ganotakis E; Katsikas G; Karvounaris S; Bizaki A; Kritikos H; Boumpas DT
    J Rheumatol; 2006 Dec; 33(12):2440-6. PubMed ID: 17014005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of anti-TNF-α treatment on lipid profile in rheumatic diseases: an analytical cohort study.
    Hassan S; Milman U; Feld J; Eder L; Lavi I; Cohen S; Zisman D
    Arthritis Res Ther; 2016 Nov; 18(1):261. PubMed ID: 27832797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy.
    Dahlqvist SR; Engstrand S; Berglin E; Johnson O
    Scand J Rheumatol; 2006; 35(2):107-11. PubMed ID: 16641043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab but not methotrexate induces extra-high levels of VLDL-triglyceride in patients with rheumatoid arthritis.
    Saiki O; Takao R; Naruse Y; Kuhara M; Imai S; Uda H
    J Rheumatol; 2007 Oct; 34(10):1997-2004. PubMed ID: 17787045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis.
    Popa C; Netea MG; Radstake T; Van der Meer JW; Stalenhoef AF; van Riel PL; Barerra P
    Ann Rheum Dis; 2005 Feb; 64(2):303-5. PubMed ID: 15231512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis.
    Allanore Y; Kahan A; Sellam J; Ekindjian OG; Borderie D
    Clin Chim Acta; 2006 Mar; 365(1-2):143-8. PubMed ID: 16176811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Distribution of blood lipids in a representative sample of the adult population of Catalonia. Research Group on Assessment of the Nutritional Status of the Catalonian Population: Biochemical Assessment].
    García Closas R; Serra Majem L; Chacón Castro P; Olmos Castellvell M; Ribas Barba L; Salleras Sanmartí L
    Med Clin (Barc); 1999 Jun; 113(1):6-12. PubMed ID: 10422069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis.
    Pollono EN; Lopez-Olivo MA; Lopez JA; Suarez-Almazor ME
    Clin Rheumatol; 2010 Sep; 29(9):947-55. PubMed ID: 20383550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients.
    Morris SJ; Wasko MC; Antohe JL; Sartorius JA; Kirchner HL; Dancea S; Bili A
    Arthritis Care Res (Hoboken); 2011 Apr; 63(4):530-4. PubMed ID: 21452265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis.
    van Halm VP; Nielen MM; Nurmohamed MT; van Schaardenburg D; Reesink HW; Voskuyl AE; Twisk JW; van de Stadt RJ; de Koning MH; Habibuw MR; van der Horst-Bruinsma IE; Dijkmans BA
    Ann Rheum Dis; 2007 Feb; 66(2):184-8. PubMed ID: 16760255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid profile changes by high activity anti-retroviral therapy.
    Duro M; Sarmento-Castro R; Almeida C; Medeiros R; Rebelo I
    Clin Biochem; 2013 Jun; 46(9):740-4. PubMed ID: 23295258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.